Karamjeet Singh Sandhu, M.D.
Hematologist-Oncologist
4.9 (78 RATINGS)
Clinical Expertise
Leukemia
Hematology & Hematopoietic Cell Transplantation
Research Area
Leukemia in geriatric population
Infections and survivorships in hematopoietic stem cell transplant recipients.
Appointments
Assistant Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation
Clinical Teams
Karamjeet Singh Sandhu, M.D., is Assistant Professor in the department of Hematology and Hematopoietic Cell Transplantation at City of Hope.
Dr. Sandhu received his medical degree from Tver State Medical Academy in Russia. He then pursued a residency in internal medicine at Hennepin County Medical Center in Minneapolis, followed by a clinical fellowship in the division of hematology, oncology and transplantation at the University of Minnesota. He completed a BMT fellowship here at City of Hope.
Board certified in Internal Medicine and Medical Oncology, Dr. Sandhu is fluent in English, Punjabi, Hindi and Russian. His area of interest includes leukemia in geriatric population, immunotherapy, graft versus host disease, impact of microbiome on hematopoietic stem cell transplant. Dr. Sandhu has presented on these topics at various conferences nationwide and has authored multiple peer reviewed journal articles and abstracts.
2016-present, Hematology
2015-present, Medical Oncology
2013-present, American Board of Internal Medicine
1994-2000, General Medicine, Tver State Medical Academy, Tver, Russia, M.D.
2015 - 2016, Bone Marrow Transplantation Fellow, City of Hope, Duarte, CA
2012-2015, Clinical Fellow, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
2009-2012, Internal Medicine Residency, Hennepin County Medical Center, Minneapolis, MN
2016 to Present, Assistant Professor, Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
Member, American Society of Hematology
Member, American Society of Clinical Oncology
Member, American Society for Blood and Marrow Transplantation
Bachanova V, Sandhu KS, Cao Q, Burke M, Verneris M, Weisdorf DJ. Prognostic Impact of CD20 Expression in Patients with Acute Lymphoblastic Leukemia Treated with Allogeneic Stem Cell Transplantation. Blood. 2011 May 12;117(19):5261-3
Majhail NS, Brunstein CG, Warlick ED, Shanley R, Sandhu KS, Wagner JE, Weisdorf DJ. Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome: Comparable Outcomes With Unrelated Umbilical Cord Blood and HLA-identical Sibling Donors. Bone Marrow Transplant. 2012 Apr;47(4):494-8
Sandhu KS, Brunstein C, Defort T, Bejanyan N, Arora M, Warlick E, Weisdorf D, Ustun C. Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndrome Patients Aged ≥70 Years. Biol Blood Marrow Transplant. 2016 Feb;22(2):390-3
Aldoss I, Yang D, Aribi A, Ali H, Sandhu K, Al Malki MM, Mei M, Salhotra A, Khaled S, Nakamura R, Snyder D, O'Donnell M, Stein AS, Forman SJ, Marcucci G, Pullarkat V. Efficacy of the combination of Venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia. Haematologica. 2018 Sep;103(9):e404-e407
Aldoss I, Dadwal S, Zhang J, Tegtmeier B, Mei M, Arslan S, Al Malki MM, Salhotra A, Ali H, Aribi A, Sandhu K, Khaled S, Snyder D, Nakamura R, Stein AS, Forman SJ, Marcucci G, Pullarkat V. Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents. Blood Advances. 2019 Dec 10;3(23):4043-4049.
Srinagesh HK, Özbek U, Kapoor U, Ayuk F, Aziz M, Ben-David K, Choe HK, DeFilipp Z, Etra A, Grupp SA, Hartwell MJ, Hexner EO, Hogan WJ, Karol AB, Kasikis S, Kitko CL, Kowalyk S, Lin JY, Major-Monfried H, Mielke S, Merli P, Morales G, Ordemann R, Pulsipher MA, Qayed M, Reddy P, Reshef R, Rösler W, Sandhu KS, Schechter T, Shah J, Sigel K, Weber D, Wölfl M, Wudhikarn K, Young R, Levine JE, Ferrara JLM. The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease. Blood Advances 2019 Dec 10;3(23):4034-4042.
Mei M, Tsai N, Mokhtari S, Al Malki M, Ali H, Salhotra A, Sandhu K, Khaled S, Smith E, Snyder D, Marcucci G, Forman S, Pullarkat, Stein A, Aldoss, Nakamura R. Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation. 2020 Aug;26(8):1425-1432.
Salhotra A, Yang D, Mokhtari S, Malki MMA, Ali H, Sandhu KS, Aribi A, Khaled S, Mei M, Budde E, Snyder D, Cao T, Spielberger R, Marcucci G, Pullarkat V, Forman SJ, Nakamura R, Stein A, Aldoss I. Outcomes of Allogeneic Hematopoietic Cell Transplantation After Salvage-Therapy With Blinatumomab in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation. 2020 Feb 5. pii: S1083-8791(20)30062-8.
Sandhu KS, Dadwal S, Yang D, Mei M, Palmer J, Salhotra A, Al Malki M, Aribi A, Ali H, Khaled S, Forman SJ, Snyder D, Nakamura R, Stein AS, Marcucci G, Aldoss I, Pullarkat V. Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous Leukemia. Biology of Blood and Marrow Transplantation. 2020 Dec;26(12): e322-e327.
S.C. Gergoudis, Z. DeFilipp, U. zbek, K.S. Sandhu, A.M. Etra, H.K. Choe, C.L. Kitko, F. Ayuk, M. Aziz, J. Baez, K. Ben-David, U. Bunworasate, I. Gandhi, E.O. Hexner, W.J. Hogan, E. Holler, S. Kasikis, S.M. Kowalyk, J.Y. Lin, P. Merli, G. Morales, R. Nakamura, R. Reshef, W. Rsler, H. Srinagesh, R. Young, Y.B. Chen, J.L.M. Ferrara, J.E. Levine. Biomarker-guided preemption of steroid-refractory graft-versus-host disease with a-1-antitrypsin, Blood Advances. Dec 2020; 4 (24): 6098–6105.
Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with 5 stars being the highest.
Ratings
4.9
Know important info medical history
4.9
Show respect for what you say
4.9
Rate provider 0-10
4.9
Recommend this provider office
4.9
Provider explain in way you understand
4.9
Provider listen carefully to you
4.8
Spend enough time with you
Reviews
10/28/22
Always good service. Never had a problem unless my wife has something to say she's had. - Verified patient
10/28/22
Highly recommend can't complain. - Verified patient
08/28/22
Always great and kind service. Very helpful with giving all information - Verified patient
08/28/22
Great - Verified patient
05/25/22
All good - Verified patient